Real-life anticoagulants comparative benefit-risk in nonvalvular atrial fibrillation (NVAF) in France (ENGEL 2)First published 04/04/2016 Last updated 23/07/2024 EU PAS number: EUPAS13017StudyFinalised
Bordeaux PharmacoEpi, University of BordeauxFrance First published: 07/02/2023Last updated 08/02/2023 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityNot-for-profitENCePP partner